Adaptive Biotechnologies
ADPT
ADPT
250 hedge funds and large institutions have $6.75B invested in Adaptive Biotechnologies in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 81 increasing their positions, 81 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
21% more funds holding
Funds holding: 206 → 250 (+44)
1.42% more ownership
Funds ownership: 82.03% → 83.45% (+1.4%)
0% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 81
Holders
250
Holding in Top 10
8
Calls
$23.8M
Puts
$4.4M
Top Buyers
| 1 | +$134M | |
| 2 | +$109M | |
| 3 | +$52.7M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$34.1M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$13.5M |
Top Sellers
| 1 | -$180M | |
| 2 | -$26.9M | |
| 3 | -$25.8M | |
| 4 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
-$24.2M |
| 5 |
Goldman Sachs
New York
|
-$20.2M |